—Mkt Cap: —P/E: —
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver suppl…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value80.31M USD
Revenue (TTM)351.50M USD
Gross Profit154.26M USD
Net Income (TTM)-22.75M USD
Revenue/Share12.95 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees753
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISINUS4568371037
Valuation
P/E (Trailing)—
P/E (Forward)-24.65
PEG—
EV/EBITDA-9.11
EV/Revenue0.23
P/S0.49
P/B0.96
EPS (TTM)-0.91
EPS (Forward)-0.26
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin44.24%
Oper. Margin-9.89%
EBITDA Margin-2.51%
Profit Margin-6.52%
ROE-11.83%
ROA-7.62%
Growth
Revenue Growth3.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.22M USD
CapEx (TTM)10.38M USD
FCF Margin-0.68%
FCF Yield—
Net Debt-93.24M USD
Net Debt/EBITDA10.58
Balance Sheet
Debt/Equity0.09
Current Ratio3.10
Quick Ratio2.47
Book Value/Sh6.684 USD
Cash/Share4.069 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)12.67 USD
Target Range12.00 USD – 14.00 USD
# Analysts3
Ownership
Shares Out.27.07M
Float23.85M
Insiders11.90%
Institutions77.76%
Short Interest
Short Ratio3.5d
Short % Float3.91%
Short % Out.3.84%
Shares Short1.05M
Short (prev mo.)1.12M
Technical
SMA 506.593 USD
SMA 2007.042 USD
Beta1.65
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)449.44K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—